Food & Food Contact Materials
CIRS Group
Chemicals
Food
Cosmetic
Medical Devices
Agrochemicals
Biocides
Carbon Neutrality
Testing
Search

US FDA Issues Proposed Rule on NAC Products as Dietary Supplements

from CIRS by

On November 16, 2026, the U.S. Food and Drug Administration issued a proposed rule that, if finalized, would reverse the exclusion of N-acetyl-L-cysteine (NAC) from the definition of dietary supplement. The proposed rule would allow NAC-containing products to be lawfully marketed as dietary supplements, provided that such products are not otherwise in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).

As discussed in a March 2022 response to two citizen petitions, NAC-containing products cannot be dietary supplements. In August 2022, the FDA issued a final guidance for industry, which explained the agency’s intent to exercise temporary enforcement discretion with respect to the sale and distribution of certain NAC-containing products that are labeled as dietary supplements. This enforcement discretion policy applies to products that would be lawfully marketed dietary supplements if NAC were not excluded from the definition of “dietary supplement” and are not otherwise in violation of the FD&C Act.

This proposed rule would establish a regulation entitled “Dietary Ingredients Not Excluded from the Dietary Supplement Definition” to provide for the lawful use of certain ingredients in dietary supplements that would otherwise be excluded from the dietary supplement definition. This action is the FDA’s first use of our rulemaking authority described in the exclusion provision of the dietary supplement definition, and NAC would be the first ingredient listed under this new regulation.

The FDA undertook a comprehensive review and did not identify any safety concerns with the use of NAC in or as a dietary supplement. FDA are now proposing this rule to provide that NAC is not excluded from the dietary supplement definition of the FD&C Act, which would allow for the lawful marketing of NAC in or as a dietary supplement.

What Can CIRS Do for You

Established in 2007, the CIRS Group is a leading product safety and regulatory consulting firm. CIRS has branch offices in the Republic of Ireland, South Korea, the United States, the United Kingdom, Japan, and China. CIRS Group utilizes its technical expertise, various resources, and international network to provide one-stop compliance services, from regulatory compliance, laboratory testing, and R&D to data services across multiple industries. This includes chemicals, cosmetics, food and food beverages, medical devices, agrochemical products, disinfectants, and consumer goods. It helps clients gain a competitive advantage by reducing business risks associated with regulatory affairs.

The vast majority of members in CIRS Food Business Division have over 10 years of professional experience in food compliance, with more than 80% holding Master’s or Doctoral degrees in food-related disciplines. The CIRS toxicology expert team consists of 24 Chinese Certified Toxicologists (DCST), 2 American Board Certified Toxicologists (DABT), and 1 European Registered Toxicologist (ERT). CIRS has provided one-stop food compliance services to over 1,000 domestic and international food and related enterprises. Leveraging its technical expertise, diverse resources, and global network, the CIRS Food Business Division offers global food compliance services, including but not limited to:

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

 

  

We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

Contact Us
+353 1 477 3710 (EU)
+44 (0) 121 663 6785 (UK)
+1 703 520 1420 (USA)
+86 571 8720 6574 (CN)
+82 2 6347 8816 (KR)
+81 070-9365-8022 (JP)